Skip to main content
Development of a multivariable risk model integrating urinary cell DNA methylation and cell‐free RNA data for the detection of significant prostate cancer
The landscape of viral associations in human cancers
Pan-cancer analysis of whole genomes
Potential for diagnosis of infectious disease from the 100,000 Genomes Project Metagenomic Dataset: Recommendations for reporting results
A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer
Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting
epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer
DESNT: A Poor Prognosis Category of Human Prostate Cancer
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
-
Our research
-
Technology platforms
-
Training and events
-
Stories and impact
